Owkin
North America, New York, United States, New York
Description
Owkin is an AI precision medicine company with a vision to find the right drug for every patient.
Investor Profile
Owkin has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series B rounds (top funding stages).
- Majority of deals are located in France.
- Strong thematic focus on Artificial Intelligence (AI), Biotechnology, Generative AI.
Stage Focus
- Seed (50%)
- Series B (50%)
Country Focus
- France (100%)
Industry Focus
- Artificial Intelligence (Ai)
- Biotechnology
- Generative Ai
- Health Care
- Innovation Management
- Manufacturing
- Software
- Web Development
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
